Leonard Sigal is a New Brunswick, New Jersey based male rheumatologist who is specialized in Rheumatology. Active license number of Leonard Sigal for Rheumatology is MA51908 in New Jersey. Leonard Sigal treat joint disease similar to orthopedists but do not perform surgeries. He diagnose and treat diseases of joints, muscle, bones and tendons which includes arthritis, back pain, muscle strains, common athletic injuries and 'collagen' diseases.
Complete Profile:
Leonard Sigal speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Specialization:
Rheumatology
Gender:
Male
Practice Address:
125 Paterson St, Clinical Academic Building - Suite 5200a, New Brunswick, New Jersey, 08901-1962
Phone:
732-235-7217
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1790850444
NPI Enumeration Date:
21 Nov, 2006
NPI Last Update On:
04 Feb, 2008
Medical Licenses:
Doctors can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Leonard Sigal are as mentioned below.
License Number
Specialization
State
Status
MA51908
Rheumatologist
New Jersey
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
66 W Gilbert St, 2nd Floor Tinton Falls, New Jersey
Zip:
07701-4947
Phone Number:
732-212-0051
Fax Number:
732-212-0713
Patients can reach Leonard Sigal at 125 Paterson St, Clinical Academic Building - Suite 5200a, New Brunswick, New Jersey or can call to book an appointment on 732-235-7217. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 November, 2024.